Egfr - epidermal growth factor receptor Gene

Also Known as Wa5; wa2; Erbb; Errp; wa-2; Errb1; 9030024J15Rik

Species: Mus musculus

Gene Type: protein coding

Gene ID: 13649

About Egfr

Chromosome 11: 16,702,203-16,868,158 forward strand.GRCm39:CM001004.3

This gene has 5 transcripts (splice variants), 283 orthologues, 53 paralogues and is associated with 180 phenotypes. Broad expression in liver adult (RPKM 26.7), liver E18 (RPKM 8.7) and 15 other tissues.

Summary

Enables epidermal growth factor binding activity and epidermal growth factor-activated receptor activity. Involved in cellular response to amino acid stimulus and positive regulation of fibroblast proliferation. Acts upstream of or within several processes, including animal organ development; epidermal growth factor receptor signaling pathway; and protein autophosphorylation. Located in several cellular components, including basolateral plasma membrane; endocytic vesicle; and perinuclear region of cytoplasm. Is expressed in several structures, including alimentary system; brain; integumental system; limb; and respiratory system. Used to study Coronavirus infectious disease and aortic valve disease. Human ortholog(s) of this gene implicated in several diseases, including colorectal cancer; lung non-small cell carcinoma (multiple); pancreatic cancer; prostate cancer; and pulmonary Tuberculosis. Orthologous to human EGFR (epidermal growth factor receptor). [provided by Alliance of Genome Resources, Apr 2022]

Egfr Products (2)

mRNA	Protein	Name
NM_207655.2	NP_997538.1	epidermal growth factor receptor isoform 1 precursor
NM_007912.4	NP_031938.1	epidermal growth factor receptor isoform 2 precursor

Gene Ontology

Molecular Function
Biological Process
Cellular Component

Molecular Function GO Annotation	Evidence	References	Source
enables epidermal growth factor binding	IDA IDA: Inferred from direct assay	7678348	MGI
enables epidermal growth factor receptor activity	IDA IDA: Inferred from direct assay	6248866	MGI
enables epidermal growth factor receptor activity	IGI IGI: Inferred from genetic interaction	16357442	MGI
enables epidermal growth factor receptor activity	IMP IMP: Inferred from mutant phenotype	18701712	MGI
enables kinase activity	IDA IDA: Inferred from direct assay	12808090	MGI
enables protein binding	IPI IPI: Inferred from physical interaction	11274221	MGI
enables protein tyrosine kinase activity	IDA IDA: Inferred from direct assay	15383614	MGI
enables protein tyrosine kinase activity	IMP IMP: Inferred from mutant phenotype	11823423	MGI
enables transmembrane receptor protein tyrosine kinase activity	IDA IDA: Inferred from direct assay	7752576	MGI
enables transmembrane receptor protein tyrosine kinase activity	IGI IGI: Inferred from genetic interaction	28783046	MGI
enables transmembrane receptor protein tyrosine kinase activity	IMP IMP: Inferred from mutant phenotype	12399441	MGI

Biological Process GO Annotation	Evidence	References	Source
involved in ERBB2-EGFR signaling pathway	IDA IDA: Inferred from direct assay	8702723	MGI
involved in ERBB2-EGFR signaling pathway	IMP IMP: Inferred from mutant phenotype	18701712	MGI
acts upstream of or within cell morphogenesis	IGI IGI: Inferred from genetic interaction	17686994	MGI
acts upstream of cell population proliferation	IGI IGI: Inferred from genetic interaction	18656477	MGI
involved in cellular response to amino acid stimulus	IDA IDA: Inferred from direct assay	22711986	MGI
acts upstream of or within cellular response to growth factor stimulus	IDA IDA: Inferred from direct assay	8702723	MGI
acts upstream of or within cerebral cortex cell migration	IMP IMP: Inferred from mutant phenotype	7618084	MGI
acts upstream of or within digestive tract morphogenesis	IMP IMP: Inferred from mutant phenotype	7618084	MGI
acts upstream of or within embryonic placenta development	IMP IMP: Inferred from mutant phenotype	7618084	MGI
acts upstream of or within epidermal growth factor receptor signaling pathway	IDA IDA: Inferred from direct assay	14712229	MGI
involved in epidermal growth factor receptor signaling pathway	IDA IDA: Inferred from direct assay	6248866	MGI
acts upstream of or within epidermal growth factor receptor signaling pathway	IGI IGI: Inferred from genetic interaction	7641815	MGI
involved in epidermal growth factor receptor signaling pathway	IGI IGI: Inferred from genetic interaction	28783046	MGI
acts upstream of or within epidermal growth factor receptor signaling pathway	IMP IMP: Inferred from mutant phenotype	17686994	MGI
involved in epidermal growth factor receptor signaling pathway	IMP IMP: Inferred from mutant phenotype	12399441	MGI
acts upstream of or within epidermis development	IMP IMP: Inferred from mutant phenotype	7618084	MGI
acts upstream of epithelial cell proliferation	IMP IMP: Inferred from mutant phenotype	7618084	MGI
acts upstream of or within eyelid development in camera-type eye	IGI IGI: Inferred from genetic interaction	9030684	MGI
acts upstream of or within hair follicle development	IGI IGI: Inferred from genetic interaction	9030684	MGI
acts upstream of or within hair follicle development	IMP IMP: Inferred from mutant phenotype	7618084	MGI
acts upstream of or within morphogenesis of an epithelial fold	IMP IMP: Inferred from mutant phenotype	7618084	MGI
involved in negative regulation of epidermal growth factor receptor signaling pathway	IDA IDA: Inferred from direct assay	23457600	MGI
involved in negative regulation of epidermal growth factor receptor signaling pathway	IMP IMP: Inferred from mutant phenotype	11823423	MGI
acts upstream of or within positive regulation of cell population proliferation	IDA IDA: Inferred from direct assay	14712229	MGI
acts upstream of or within positive regulation of cell population proliferation	IGI IGI: Inferred from genetic interaction	7641815	MGI
acts upstream of or within positive regulation of epithelial cell proliferation	IMP IMP: Inferred from mutant phenotype	7618084	MGI
involved in positive regulation of fibroblast proliferation	IMP IMP: Inferred from mutant phenotype	20208556	MGI
acts upstream of or within protein autophosphorylation	IDA IDA: Inferred from direct assay	15314156	MGI
acts upstream of or within regulation of cell population proliferation	IGI IGI: Inferred from genetic interaction	11818567	MGI
acts upstream of or within regulation of peptidyl-tyrosine phosphorylation	IMP IMP: Inferred from mutant phenotype	11940581	MGI
acts upstream of or within salivary gland morphogenesis	IMP IMP: Inferred from mutant phenotype	10521784	MGI
acts upstream of or within signal transduction	IDA IDA: Inferred from direct assay	11940581	MGI

Cellular Component GO Annotation	Evidence	References	Source
located in basolateral plasma membrane	IDA IDA: Inferred from direct assay	7723235	MGI
located in cell surface	IDA IDA: Inferred from direct assay	23918928	MGI
located in endocytic vesicle	IDA IDA: Inferred from direct assay	10534613	MGI
located in intracellular anatomical structure	IDA IDA: Inferred from direct assay	10534613	MGI
located in nucleus	IDA IDA: Inferred from direct assay	20208556	MGI
located in perinuclear region of cytoplasm	IDA IDA: Inferred from direct assay	20208556	MGI
is active in plasma membrane	IDA IDA: Inferred from direct assay	6248866	MGI
located in plasma membrane	IDA IDA: Inferred from direct assay	7641815	MGI
is active in plasma membrane	IGI IGI: Inferred from genetic interaction	28783046	MGI

EXP: Inferred from Experiment IDA: Inferred from direct assay IPI: Inferred from physical interaction IMP: Inferred from mutant phenotype IGI: Inferred from genetic interaction IEP: Inferred from expression pattern

Egfr Protein Structure

Recep_L_domain

Furin-like

Recep_L_domain

GF_recep_IV

TM_ErbB1

PTKc_EGFR

0
200
400
600
800
1000
1210 a.a.

Protein Preferred Names	Protein Names
epidermal growth factor receptor	avian erythroblastic leukemia viral (v-erb-b) oncogene homolog waved 2

Recombinant Egfr Proteins

Cat. No.	상품명	Accession	Purity
HY-P72988	EGFR Protein, Mouse (HEK293, Fc)	Q01279 (L25-S647)	≥ 95%, as determined by reducing SDS-PAGE.
HY-P72989	EGFR Protein, Mouse (HEK293, His, solution)	Q01279 (L25-S647)	≥ 95%, as determined by reducing SDS-PAGE.

Related Agents

Approval
Clinical Phase
Pre-clinical Phase

Approval

Bioactive Molecules (51)

Cat. No.	상품명	효과	Purity	Rare Diseases
HY-15772	Osimertinib	Inhibitor	99.96%	Yes
HY-P9907	Trastuzumab	Inhibitor	99.80%	Unkown
HY-P9905	Cetuximab	Inhibitor	99.81%	Unkown
HY-50895	Gefitinib	Inhibitor	99.99%	Yes
HY-138298A	Trastuzumab deruxtecan	Inhibitor	99.89%	Unkown
HY-50896	Erlotinib	Inhibitor	99.99%	Yes
HY-10261	Afatinib	Inhibitor	99.92%	Yes
HY-138298	Trastuzumab deruxtecan (solution)	Inhibitor	99.40%	Unkown
HY-50898	Lapatinib	Inhibitor	99.83%	Yes
HY-16069	Tucatinib	Inhibitor	99.82%	Yes
HY-P9921	Trastuzumab emtansine	Inhibitor	99.74%	Unkown
HY-32721	Neratinib	Inhibitor	99.94%	Yes
HY-P9985	Disitamab vedotin	Inhibitor	99.06%	Unkown
HY-13272	Dacomitinib	Inhibitor	99.74%	Yes
HY-15772A	Osimertinib mesylate	Inhibitor	99.97%	Yes
HY-109061	Lazertinib	Inhibitor	99.87%	Unkown
HY-P9921A	Trastuzumab emtansine (solution)		98.27%	Unkown
HY-12008	Erlotinib Hydrochloride	Inhibitor	99.94%	Yes
HY-10261A	Afatinib dimaleate	Inhibitor	99.74%	Yes
HY-112870	Firmonertinib	Inhibitor	99.89%	Unkown
HY-112823	Almonertinib	Inhibitor	99.83%	Unkown
HY-50895A	Gefitinib hydrochloride	Inhibitor	99.85%	Yes
HY-104065	Pyrotinib	Inhibitor	99.89%	Unkown
HY-132842	Sunvozertinib	Inhibitor	99.62%	Unkown
HY-N0281	Daphnetin	Inhibitor	99.77%	Unkown
HY-135815	Mobocertinib	Inhibitor	99.60%	Yes
HY-15164A	Icotinib	Inhibitor	99.96%	Yes
HY-79077	Osimertinib dimesylate	Inhibitor	99.96%	Yes
HY-32721B	Neratinib maleate	Inhibitor	99.74%	Yes
HY-164718	Sevabertinib	Inhibitor	99.90%	Unkown
HY-50898A	Lapatinib ditosylate	Inhibitor	99.96%	Yes
HY-19730	Olmutinib	Inhibitor	99.88%	Unkown
HY-112870A	Firmonertinib mesylate	Inhibitor	99.97%	Unkown
HY-15772R	Osimertinib (Standard)	Inhibitor	99.69%	Unkown
HY-50898B	Lapatinib ditosylate monohydrate	Inhibitor	99.99%	Yes
HY-104065B	Pyrotinib dimaleate	Inhibitor	98.04%	Unkown
HY-112823A	Almonertinib mesylate	Inhibitor	99.67%	Unkown
HY-112823B	Almonertinib hydrochloride	Inhibitor	98.92%	Unkown
HY-135815A	Mobocertinib succinate	Inhibitor	99.83%	Yes
HY-50896R	Erlotinib (Standard)	Inhibitor	99.97%	Unkown
HY-16069A	Tucatinib hemiethanolate	Inhibitor	98.82%	Yes
HY-15164	Icotinib Hydrochloride	Inhibitor	99.89%	Yes
HY-50895R	Gefitinib (Standard)	Inhibitor	99.94%	Unkown
HY-118263	Dacomitinib hydrate	Inhibitor	99.54%	Unkown
HY-12008R	Erlotinib Hydrochloride (Standard)	Inhibitor	99.73%	Unkown
HY-135815B	Mobocertinib mesylate	Inhibitor	/	Unkown
HY-50898C	Lapatinib tosylate	Inhibitor	/	Unkown
HY-10261D	Afatinib oxalate	Inhibitor	/	Unkown
HY-50895B	Gefitinib dihydrochloride	Inhibitor	/	Unkown
HY-101820A	Simotinib hydrochloride	Inhibitor	/	Unkown
HY-12008A	Erlotinib mesylate	Inhibitor	/	Unkown

Inhibitory Antibodies (8)

Cat. No.	상품명	효과	Purity	Rare Diseases
HY-P9977	Amivantamab	Inhibitor	99.90%	Unkown
HY-P9912	Pertuzumab	Inhibitor	99.80%	Unkown
HY-P99041	Panitumumab	Inhibitor	99.77%	Unkown
HY-P99380	Zanidatamab	Inhibitor	98.56%	Unkown
HY-P99507	Zenocutuzumab	Inhibitor	99.9%	Unkown
HY-P9968	Nimotuzumab	Inhibitor	96.80%	Unkown
HY-P9964	Necitumumab	Inhibitor	99.82%	Unkown
HY-P99030	Margetuximab	Inhibitor	≥99.0%	Unkown

Clinical Phase

Bioactive Molecules (81)

Cat. No.	상품명	효과	Purity	Phase
HY-14596	Genistein	Inhibitor	99.82%	Phase 4
HY-137433	Befotertinib	Inhibitor	99.77%	Phase 4
HY-131686	Ganglioside GT1b (bovine) ammonium	Activator	98.0%	Phase 4
HY-50895G	Gefitinib (GMP)	Inhibitor	/	Phase 4
HY-P99813	Patritumab deruxtecan		99.08%	Phase 3
HY-164702	BL-B01D1	Inhibitor	98.40%	Phase 3
HY-18750	Zorifertinib	Inhibitor	99.37%	Phase 3
HY-171265	Becotatug vedotin	Inhibitor	96.99%	Phase 3
HY-15729	Rociletinib	Inhibitor	99.67%	Phase 3
HY-15730	Poziotinib	Inhibitor	99.96%	Phase 3
HY-132259	Depatuxizumab mafodotin		99.65%	Phase 3
HY-12872	Nazartinib	Inhibitor	99.53%	Phase 3
HY-164762	Trastuzumab rezetecan	Inhibitor	98.01%	Phase 3
HY-112299	Zipalertinib	Inhibitor	99.62%	Phase 3
HY-139920	Oritinib	Inhibitor	99.59%	Phase 3
HY-19803	Naquotinib mesylate	Inhibitor	98.06%	Phase 3
HY-19816A	Avitinib maleate	Inhibitor	99.86%	Phase 3
HY-13314	Tesevatinib	Inhibitor	99.41%	Phase 3
HY-120590	Ruserontinib	Inhibitor	99.32%	Phase 3
HY-P990697	Anvatabart	Inhibitor	98.15%	Phase 3
HY-138751A	limertinib diTFA	Inhibitor	98.96%	Phase 3
HY-118998	TX2-121-1	Degrader	/	Phase 3
HY-10530A	Varlitinib tosylate	Inhibitor	/	Phase 3
HY-N14349	Asterriquinone	Inhibitor	/	Phase 3
HY-109189A	Rezivertinib hydrochloride	Inhibitor	/	Phase 3
HY-106204	Nelipepimut-S		/	Phase 3
HY-172820	Trastuzumab envedotin	Inhibitor	/	Phase 3
HY-13050	Sapitinib	Inhibitor	99.93%	Phase 2
HY-10367	Canertinib	Inhibitor	99.74%	Phase 2
HY-32718	Pelitinib	Inhibitor	99.13%	Phase 2
HY-153268	Silevertinib	Inhibitor	99.74%	Phase 2
HY-10045	AEE788	Inhibitor	98.39%	Phase 2
HY-14674	CP-724714	Inhibitor	98.72%	Phase 2
HY-10333	BMS-690514	Inhibitor	99.68%	Phase 2
HY-19985	PF-06459988	Inhibitor	99.10%	Phase 2
HY-12972	Mavelertinib	Inhibitor	99.34%	Phase 2
HY-17632	Tarloxotinib bromide	Inhibitor	98.75%	Phase 2
HY-172429A	Enozertinib hemihydrate	Inhibitor	99.98%	Phase 2
HY-19815	Olafertinib	Inhibitor	99.51%	Phase 2
HY-10251	BMS-599626	Inhibitor	98.56%	Phase 2
HY-107367A	Epertinib hydrochloride	Inhibitor	98.15%	Phase 2
HY-155537	Pruvonertinib	Inhibitor	99.50%	Phase 2
HY-19909	NRC-2694	Antagonist	99.84%	Phase 2
HY-153974	BBT-176	Inhibitor	98.98%	Phase 2
HY-W423595	BEBT-109	Inhibitor	98.72%	Phase 2
HY-107367	Epertinib	Inhibitor	≥98.0%	Phase 2
HY-P991092	IBI-334	Inhibitor	98.18%	Phase 2
HY-177414	BB-1701	Inhibitor	98.81%	Phase 2
HY-101756	SDZ281-977		98.00%	Phase 2
HY-164387A	Sutetinib maleate	Inhibitor	/	Phase 2
HY-10223	CUDC-101	Inhibitor	99.05%	Phase 1
HY-13501	Mubritinib	Inhibitor	99.91%	Phase 1
HY-164202	ORM-5029	Inhibitor	96.53%	Phase 1
HY-18957	Lifirafenib	Inhibitor	98.01%	Phase 1
HY-144680	BLU-945	Inhibitor	99.61%	Phase 1
HY-14346	PD153035	Inhibitor	98.56%	Phase 1
HY-171124	Tilatamig samrotecan	Inhibitor	95.26%	Phase 1
HY-136789	Tuxobertinib	Inhibitor	99.88%	Phase 1
HY-15196	TAK-285	Inhibitor	98.99%	Phase 1
HY-103443	HKI-357	Inhibitor	99.24%	Phase 1
HY-B0794	AZ7550	Inhibitor	97.09%	Phase 1
HY-116437	Selatinib	Inhibitor	98.56%	Phase 1
HY-155079	DZD1516	Inhibitor	99.62%	Phase 1
HY-101820	Simotinib	Inhibitor	99.39%	Phase 1
HY-10346	AV-412	Inhibitor	99.17%	Phase 1
HY-153110	Larotinib	Inhibitor	99.50%	Phase 1
HY-139300	Epitinib	Inhibitor	99.95%	Phase 1
HY-164694	Emupertinib	Inhibitor	99.10%	Phase 1
HY-171747	AMT-562	Antagonist	98.65%	Phase 1
HY-177895	IAM1363	Inhibitor	99.40%	Phase 1
HY-111553	TAS0728	Inhibitor	99.71%	Phase 1
HY-128778	Gozanertinib	Inhibitor	98.30%	Phase 1
HY-164307	Pebezertinib	Inhibitor	99.56%	Phase 1
HY-15732	BGB-102	Inhibitor	99.52%	Phase 1
HY-164464	BPI-15086	Inhibitor	/	Phase 1
HY-104066A	Theliatinib tartrate		/	Phase 1
HY-181954	ZW-49	Inhibitor	/	Phase 1
HY-177710	MEDI4276		/	Phase 1
HY-110039	BIBX 1382 dihydrochloride	Inhibitor	/	Phase 1
HY-153856	TAS2940	Inhibitor	/	Phase 1
HY-110333	BMS-599626 dihydrochloride	Inhibitor	/	Phase 1

Inhibitory Antibodies (47)

Cat. No.	상품명	효과	Purity	Phase
HY-P99041A	Panitumumab (anti-EGFR)	Inhibitor	99.02%	Phase 4
HY-P99969	Inetetamab	Inhibitor	96.54%	Phase 4
HY-P99854A	Disitamab (powder)	Inhibitor	98.44%	Phase 4
HY-P99041B	Panitumumab (powder)	Inhibitor	/	Phase 4
HY-P99275	Patritumab	Inhibitor	99.28%	Phase 3
HY-P99406	Petosemtamab	Degrader	99.90%	Phase 3
HY-P99676	Izalontamab	Inhibitor	99.89%	Phase 3
HY-P99849	Depatuxizumab	Inhibitor	99.58%	Phase 3
HY-P99155	Zalutumumab		98.34%	Phase 3
HY-P990049	Becotatug	Inhibitor	99.00%	Phase 3
HY-P99437	Anbenitamab	Inhibitor	99.22%	Phase 3
HY-P99455	Bafisontamab	Inhibitor	99.9%	Phase 3
HY-P99831	Coprelotamab		/	Phase 3
HY-P99630	Gancotamab antibody	Inhibitor	≥99.0%	Phase 3
HY-P991588	HLX-22	Antagonist	99.47%	Phase 3
HY-P991508	Sym004	Inhibitor	98.97%	Phase 3
HY-P99155A	Zalutumumab (powder)	Inhibitor	/	Phase 3
HY-P99268	Seribantumab	Inhibitor	96.043%	Phase 2
HY-P9969	Matuzumab		99.50%	Phase 2
HY-P99936	Elgemtumab	Inhibitor	99.00%	Phase 2
HY-P99778	Ontuxizumab		99.85%	Phase 2
HY-P990314	AFM24	Inhibitor	96.26%	Phase 2
HY-P99295	Imgatuzumab	Inhibitor	99.41%	Phase 2
HY-P990071	Fepixnebart	Inhibitor	96.46%	Phase 2
HY-P99605	Cinrebafusp alfa	Inhibitor	98.53%	Phase 2
HY-P99306	Modotuximab	Inhibitor	99.08%	Phase 2
HY-P99628	Futuximab	Inhibitor	98.09%	Phase 2
HY-P991237	Nezutatug	Inhibitor	99.9%	Phase 2
HY-P991571	GC1118		99.22%	Phase 2
HY-P990913	Dalmitamig		97.158%	Phase 2
HY-P99672	Istiratumab	Inhibitor	98.45%	Phase 2
HY-P991238	MEDI4276 Antibody	Inhibitor	96.5212%	Phase 2
HY-P9994	Pertuzumab zuvotolimod	Inhibitor	98.64%	Phase 2
HY-P991507	SCT200	Inhibitor	99.09%	Phase 2
HY-P991240	CDX-3379	Inhibitor	99.38%	Phase 2
HY-P991524	MM-111	Inhibitor	/	Phase 2
HY-P99500	Cetuximab sarotalocan	Inhibitor	/	Phase 2
HY-P991233	BAT1006	Inhibitor	/	Phase 2
HY-P991572	MM-151	Antagonist	/	Phase 2
HY-P99896	Runimotamab		99.00%	Phase 1
HY-P99386	Vesencumab	Inhibitor	99.34%	Phase 1
HY-P99304	Lumretuzumab	Inhibitor	≥99.0%	Phase 1
HY-P99685	Laprituximab emtansine	Inhibitor	97.66%	Phase 1
HY-P991235	FS102	Degrader	/	Phase 1
HY-P990609	KHK-2866		98.23%	Phase 1
HY-P991984	SIBP-03	Inhibitor	/	Phase 1
HY-P991244	REGN-1400	Inhibitor	/	Phase 1

Pre-clinical Phase

Bioactive Molecules (957)

Cat. No.	상품명	효과	Purity	Rare Diseases
HY-12000	AG490	Inhibitor	99.86%	Unkown
HY-P0221	PACAP (1-38), human, ovine, rat	Inducer	99.99%	Unkown
HY-13524	AG-1478	Inhibitor	99.57%	Unkown
HY-P10408	Candidalysin	Activator	99.81%	Unkown
HY-101084	NSC 228155	Activator	99.58%	Unkown
HY-164992	Trastuzumab vedotin	Inhibitor	98.05%	Unkown
HY-13595	Chrysophanol	Inhibitor	99.73%	Unkown
HY-N0280	Corosolic acid		99.95%	Unkown
HY-16558	Butein	Inhibitor	99.64%	Unkown
HY-N2409	Delphinidin chloride	Inhibitor	98.0%	Unkown
HY-171135	Cetuximab MMAE	Inhibitor	99.64%	Unkown
HY-100848	TX1-85-1	Inhibitor	99.65%	Unkown
HY-12461	WS6	Activator	99.30%	Unkown
HY-100958	4-DAMP	Inhibitor	99.96%	Unkown
HY-B0793	AZ-5104	Inhibitor	99.91%	Unkown
HY-156698	HJM-561	Degrader	99.52%	Unkown
HY-N7922	Urolithin M5		97.31%	Unkown
HY-100742	GNE-140 racemate	Inhibitor	99.25%	Unkown
HY-19816	Avitinib	Inhibitor	99.95%	Unkown
HY-123921	Gefitinib-based PROTAC 3	Degrader	99.98%	Unkown
HY-15644	Tyrphostin 23	Inhibitor	98.19%	Unkown
HY-168438	ERBB agonist-1	Agonist	99.16%	Unkown
HY-14596R	Genistein (Standard)	Inhibitor	98.70%	Unkown
HY-108052	Delphinidin 3-glucoside chloride	Inhibitor	99.89%	Unkown
HY-N0447	8-Gingerol	Inhibitor	99.72%	Unkown
HY-162713	MTX-531	Inhibitor	99.87%	Unkown
HY-120852	JG26	Inhibitor	98.14%	Unkown
HY-112411	PD 174265	Inhibitor	98.35%	Unkown
HY-W016412	Coenzyme Q0	Inhibitor	99.79%	Unkown
HY-129550	BI-4020	Inhibitor	99.30%	Unkown
HY-13896	PD168393	Inhibitor	98.01%	Unkown
HY-41404	Piperonylic acid		99.94%	Unkown
HY-109189	Rezivertinib	Inhibitor	99.62%	Unkown
HY-48999A	FSK hydrochloride		99.97%	Unkown
HY-100434	PD-161570	Inhibitor	98.78%	Unkown
HY-131864	SJF-1528	Degrader	98.90%	Unkown
HY-141640	MS154	Inhibitor	99.71%	Unkown
HY-138751	limertinib	Inhibitor	99.15%	Unkown
HY-N2450	Sulforaphene	Inhibitor	99.78%	Unkown
HY-N0211	Cyasterone	Inhibitor	99.58%	Unkown
HY-18609	PD158780	Inhibitor	99.47%	Unkown
HY-155736	MAPK-IN-2	Inhibitor	99.66%	Unkown
HY-W782083	p-SCN-Bn-NOTA trihydrochloride		99.75%	Unkown
HY-125168	EGA	Modulator	99.76%	Unkown
HY-N2184	Furanodienone		99.90%	Unkown
HY-14596S	Genistein-d4	Inhibitor	98.81%	Unkown
HY-10530	Varlitinib	Inhibitor	99.92%	Yes
HY-141676	HyT36	Degrader	96.0%	Unkown
HY-N7005	Clitorin	Inhibitor	99.45%	Unkown
HY-15375	Allitinib	Inhibitor	98.88%	Unkown
HY-100213	EAI045	Inhibitor	99.06%	Unkown
HY-10322	Falnidamol	Inhibitor	99.41%	Unkown
HY-N0891	Tubeimoside II	Inhibitor	99.90%	Unkown
HY-138916	PF-06672131	Inhibitor	99.47%	Unkown
HY-10367A	Canertinib dihydrochloride	Inhibitor	99.68%	Unkown
HY-157229	STX-721	Inhibitor	98.43%	Unkown
HY-115605	CN009543V	Agonist	99.37%	Unkown
HY-156712	Depatuxizumab MMAE	Inhibitor	99.73%	Unkown
HY-20878	Tyrphostin AG 879	Inhibitor	99.26%	Unkown
HY-N9330	Broussoflavonol F	Inhibitor	98.11%	Unkown
HY-B0794B	AZ7550 Mesylate	Inhibitor	98.70%	Unkown
HY-10261B	(E/Z)-Afatinib	Inhibitor	99.98%	Unkown
HY-18963	Lavendustin A	Inhibitor	98.95%	Unkown
HY-131865	SJF-1521	Degrader	99.65%	Unkown
HY-124813	PDZ1i	Inhibitor	99.29%	Unkown
HY-161536	PROTAC EGFR degrader 9	Inhibitor	98.35%	Unkown
HY-N2510	Myristicin	Inhibitor	99.89%	Unkown
HY-123578	NSC689857	Inhibitor	99.49%	Unkown
HY-N2524	Camelliaside A	Ligand	99.65%	Unkown
HY-104066	Theliatinib	Inhibitor	99.72%	Unkown
HY-109061B	Lazertinib mesylate	Inhibitor	99.85%	Unkown
HY-108016	Peruvoside	Inhibitor	99.32%	Unkown
HY-157581	MS39	Degrader	99.89%	Unkown
HY-10325	CL-387785	Inhibitor	99.31%	Unkown
HY-108484	PP 3	Inhibitor	99.20%	Unkown
HY-134877	BAY 2476568	Inhibitor	99.88%	Unkown
HY-13464	ALK-IN-1	Inhibitor	99.42%	Unkown
HY-112097	E260	Inhibitor	99.92%	Unkown
HY-12026	WZ4002	Inhibitor	98.99%	Unkown
HY-137191	CH7233163	Inhibitor	99.41%	Unkown
HY-150611	EGFR-IN-70	Inhibitor	98.12%	Unkown
HY-115481	EphB1-IN-1	Inhibitor	99.51%	Unkown
HY-147858	PROTAC EGFR degrader 7	Degrader	99.48%	Unkown
HY-N2445	Flavokawain C	Inhibitor	99.79%	Unkown
HY-19729	Naquotinib	Inhibitor	98.10%	Unkown
HY-107364	MTX-211	Inhibitor	99.81%	Unkown
HY-172429	Enozertinib	Inhibitor	98.86%	Unkown
HY-147219A	SIAIS164018 hydrochloride	Degrader	98.06%	Unkown
HY-156640	Rocbrutinib	Inhibitor	99.76%	Unkown
HY-103442	CGP52411	Inhibitor	99.82%	Unkown
HY-N4201	β-Hydroxyisovalerylshikonin	Inhibitor	99.83%	Unkown
HY-15772S	Osimertinib-d6	Inhibitor	99.70%	Unkown
HY-128862	EGFR-IN-7	Inhibitor	99.76%	Unkown
HY-128576	DS21360717		99.80%	Unkown
HY-12013	PD153035 Hydrochloride	Inhibitor	99.48%	Unkown
HY-W018800	4(3H)-Quinazolinone	Inhibitor	99.89%	Unkown
HY-B1394	Khellin	Inhibitor	99.66%	Unkown
HY-17499	EGFR-IN-12	Inhibitor	99.60%	Unkown
HY-15844	AG-825	Inhibitor	98.13%	Unkown
HY-13895	WHI-P154	Inhibitor	98.77%	Unkown
HY-162299	EGFR kinase inhibitor 3	Inhibitor	99.03%	Unkown
HY-163094	EGFR-IN-95	Inhibitor	98.76%	Unkown
HY-12001	WZ-3146	Inhibitor	99.28%	Unkown
HY-13897	CNX-2006	Inhibitor	98.00%	Unkown
HY-161275	BI-4732	Inhibitor	98.81%	Unkown
HY-130616	EGFR-IN-11	Inhibitor	98.76%	Unkown
HY-147941A	MS9427 TFA	Degrader	98.38%	Unkown
HY-147183B	JBJ-09-063 hydrochloride	Inhibitor	99.37%	Unkown
HY-111415	EGFR-IN-5	Inhibitor	99.49%	Unkown
HY-12010	BMS-599626 Hydrochloride	Inhibitor	98.90%	Unkown
HY-153796	PROTAC Her3 Degrader-8	Degrader	99.60%	Unkown
HY-172470	DSPE-PEG2000-GE11		95.29%	Unkown
HY-161408	GePhos1		98.88%	Unkown
HY-144304	PROTAC EGFR degrader 2	Inhibitor	95.09%	Unkown
HY-18603	FIIN-3	Inhibitor	99.01%	Unkown
HY-139617	Sec61-IN-3	Inhibitor	99.22%	Unkown
HY-13427	Allitinib tosylate	Inhibitor	99.54%	Unkown
HY-147942	MS9449	Degrader	98.95%	Unkown
HY-136430	JCN037	Inhibitor	99.09%	Unkown
HY-43533	Tarlox-TKI	Inhibitor	98.79%	Unkown
HY-161537	EGFR ligand-9	Inhibitor	98.80%	Unkown
HY-P2503	EGFR Protein Tyrosine Kinase Substrate		99.46%	Unkown
HY-101960A	Tyrphostin A51	Inhibitor	99.0%	Unkown
HY-153901	PROTAC EGFR degrader 8	Degrader	98.90%	Unkown
HY-P4082	ErbB-2-binding peptide-1	Ligand	99.52%	Unkown
HY-N1988	Cucurbitacin IIa	Inhibitor	99.90%	Unkown
HY-110406	13(S)-HPODE	Activator	95.05%	Unkown
HY-N1073	Wighteone	Inhibitor	98.71%	Unkown
HY-146349	PROTAC EGFR degrader 4	Degrader	99.70%	Unkown
HY-149530	EGFR-IN-86	Inhibitor	99.92%	Unkown
HY-P5314	OK2	Inhibitor	99.13%	Unkown
HY-175252	PROTAC EGFR degrader 14	Degrader	99.26%	Unkown
HY-161633	PROTAC EGFR degrader 11	Degrader	99.20%	Unkown
HY-117155	PKI-166	Inhibitor	98.92%	Unkown
HY-163428	Perzebertinib	Inhibitor	/	Unkown
HY-12029	WZ8040	Inhibitor	98.29%	Unkown
HY-147183A	JBJ-09-063 TFA	Inhibitor	99.64%	Unkown
HY-150023	BI-1622	Inhibitor	98.02%	Unkown
HY-138627A	AST5902 trimesylate	Inhibitor	98.75%	Unkown
HY-112293	GW2974		99.16%	Unkown
HY-W013857	Lavendustin C	Inhibitor	98.17%	Unkown
HY-P1828A	EGFRvIII peptide (PEPvIII) TFA		98.73%	Unkown
HY-P11308	Cys-GE11		98.03%	Unkown
HY-175839	PROTAC EGFR degrader 15	Degrader	99.23%	Unkown
HY-101429	RG13022	Inhibitor	96.74%	Unkown
HY-RS04209	EGFR Human Pre-designed siRNA Set A	Inhibitor	/	Unkown
HY-123952	RTC-5	Inhibitor	99.37%	Unkown
HY-19985A	(3S,4S)-PF-06459988		98.97%	Unkown
HY-124674A	CCT365623 hydrochloride	Inhibitor	98.07%	Unkown
HY-103566	LY456236	Inhibitor	99.57%	Unkown
HY-P10792	HER2-targeted peptide H6F		98.85%	Unkown
HY-123035	Gamendazole	Inhibitor	99.44%	Unkown
HY-101219	VEGFR-IN-1	Inhibitor	99.07%	Unkown
HY-157579	MS154N		99.30%	Unkown
HY-15336	AG 555	Inhibitor	98.0%	Unkown
HY-177008	PROTAC HER2 degrader-1	Degrader	98.0%	Unkown
HY-79511	FAAH-IN-2	Ligand	99.12%	Unkown
HY-103440	EGFR/ErbB-2/ErbB-4 inhibitor-3	Inhibitor	96.78%	Unkown
HY-161126	EGFR-IN-98	Inhibitor	99.12%	Unkown
HY-101041	(E)-AG 556	Inhibitor	99.91%	Unkown
HY-126320	EGFR-IN-8	Inhibitor	98.01%	Unkown
HY-164919	Calotatug ginistinag	Inhibitor	95.94%	Unkown
HY-100214	EAI001	Inhibitor	99.93%	Unkown
HY-15769	WHI-P180	Inhibitor	99.84%	Unkown
HY-150024	BI-4142	Inhibitor	98.02%	Unkown
HY-142283AS	Dosimertinib-d5 mesylate	Inhibitor	99.50%	Unkown
HY-111138	CZC-8004	Inhibitor	99.81%	Unkown
HY-112474	Tyrphostin AG 112	Inhibitor	98.31%	Unkown
HY-112420	EGFR/ErbB-2-IN-2	Inhibitor	99.45%	Unkown
HY-118532	Tyrphostin AG30	Inhibitor	98.51%	Unkown
HY-131864A	SJF-1528 hemihydrate	Degrader	98.90%	Unkown
HY-157480	EGFR/AURKB-IN-1	Inhibitor	99.43%	Unkown
HY-P10224A	G7-18NATE TFA		98.06%	Unkown
HY-12806	AG1557	Inhibitor	99.54%	Unkown
HY-101450	PF-6274484	Inhibitor	98.76%	Unkown
HY-101042	AG-494	Inhibitor	98.69%	Unkown
HY-142512	EGFR-IN-24	Inhibitor	98.71%	Unkown
HY-N7424	4,7-Dihydroxycoumarin	Inhibitor	98.25%	Unkown
HY-172920	Wnt/β-catenin-IN-6	Inhibitor	98.34%	Unkown
HY-N6577	Astragaloside VI		99.95%	Unkown
HY-15729A	Rociletinib hydrobromide	Inhibitor	98.04%	Yes
HY-107459	(E/Z)-AG490	Inhibitor	99.71%	Unkown
HY-156284	EGFR-IN-89	Inhibitor	98.75%	Unkown
HY-N6932	Voacamine		99.64%	Unkown
HY-13984	NT-1	Inhibitor	99.40%	Unkown
HY-135805B	(Rac)-JBJ-04-125-02 acetate		/	Unkown
HY-119944	JND3229	Inhibitor	99.38%	Unkown
HY-153110A	Larotinib mesylate hydrate	Inhibitor	98.66%	Unkown
HY-141481	DP-C-4	Inhibitor	98.15%	Unkown
HY-156741A	EGFR-IN-87 hydrochloride	Inhibitor	98.0%	Unkown
HY-149889	EGFR-IN-78	Inhibitor	99.57%	Unkown
HY-145960A	MC-Val-Cit-PAB-Amide-TLR7 agonist 4 formic	Agonist	97.70%	Unkown
HY-100923	H-9 Dihydrochloride	Inhibitor	98.98%	Unkown
HY-179572	STA-013	Inhibitor	99.18%	Unkown
HY-164763	SHR-A1201	Inhibitor	97.35%	Unkown
HY-112345	PD-089828	Inhibitor	98.07%	Unkown
HY-139997	DDC-01-163	Degrader	99.05%	Unkown
HY-P11078A	LARLLT TFA		99.89%	Unkown
HY-101006	Methyl 2,5-dihydroxycinnamate	Inhibitor	99.77%	Unkown
HY-50896S	Erlotinib-d6	Inhibitor	99.84%	Unkown
HY-158149	T-1-PMPA	Inhibitor	99.70%	Unkown
HY-133780	Afatinib impurity 11	Inhibitor	99.10%	Unkown
HY-161927	EGFR-TK-IN-4	Inhibitor	99.90%	Unkown
HY-P1855	HER2/neu (654-662) GP2		98.26%	Unkown
HY-143337	EGFR-IN-47	Inhibitor	96.01%	Unkown
HY-131686A	Ganglioside GT1b (porcine) ammonium	Activator	98%	Unkown
HY-RS04472	ERBB4 Human Pre-designed siRNA Set A	Inhibitor	/	Unkown
HY-RS04466	ERBB2 Human Pre-designed siRNA Set A	Inhibitor	/	Unkown
HY-161781	HVH-2930	Inhibitor	96.54%	Unkown
HY-N1166	Tephrosin		98.02%	Unkown
HY-50898S	Lapatinib-d4	Inhibitor	99.02%	Unkown
HY-103441	JNJ28871063 hydrochloride	Inhibitor	98.36%	Unkown
HY-100064	O-Desmethyl gefitinib	Inhibitor	99.40%	Unkown
HY-15801	HG-14-10-04	Inhibitor	98.53%	Unkown
HY-172414	Andamertinib	Inhibitor	99.06%	Unkown
HY-162890	EGFR-IN-122	Inhibitor	99.98%	Unkown
HY-170820	XYD049	Inhibitor	99.46%	Unkown
HY-151159	DHFR-IN-4	Inhibitor	99.19%	Unkown
HY-101426	RG14620	Inhibitor	99.02%	Unkown
HY-101522	CHMFL-EGFR-202	Inhibitor	99.75%	Unkown
HY-156872	MTX-216	Inhibitor	/	Unkown
HY-157582	MS39N	Control	98.0%	Unkown
HY-50895S2	Gefitinib-d3	Inhibitor	98.39%	Unkown
HY-113599	Isoprocurcumenol	Activator	95.41%	Unkown
HY-13450	ZM 449829	Inhibitor	99.73%	Unkown
HY-112870AS	Firmonertinib-d3 mesylate		99.00%	Unkown
HY-50895S	Gefitinib-d8	Inhibitor	98.42%	Unkown
HY-135805A	(Rac)-JBJ-04-125-02	Inhibitor	/	Unkown
HY-131067	EMI56	Inhibitor	99.36%	Unkown
HY-100962	(E)-AG 99	Inhibitor	98.12%	Unkown
HY-19617	EGFR-IN-1	Inhibitor	/	Unkown
HY-19617A	EGFR-IN-1 hydrochloride	Inhibitor	/	Unkown
HY-152852	Mefatinib free base	Inhibitor	99.40%	Unkown
HY-138627	AST5902	Inhibitor	/	Unkown
HY-147183	JBJ-09-063	Inhibitor	/	Unkown
HY-130608	Mutated EGFR-IN-3	Inhibitor	/	Unkown
HY-147941	MS9427	Degrader	95.29%	Unkown
HY-139300A	Epitinib succinate	Inhibitor	99.01%	Unkown
HY-115716	EGFR-IN-17	Inhibitor	98.18%	Unkown
HY-132842A	(S)-Sunvozertinib	Inhibitor	99.05%	Unkown
HY-P992138	Vadalentamig	Inhibitor	95.29%	Unkown
HY-101958	Tyrphostin 25	Inhibitor	99.00%	Unkown
HY-P2673	Lys-Arg-Thr-Leu-Arg-Arg		/	Unkown
HY-170928	DA-0157	Inhibitor	99.59%	Unkown
HY-U00002	ZD-4190	Inhibitor	98.08%	Unkown
HY-135805	JBJ-04-125-02	Inhibitor	/	Unkown
HY-P992128	Rinumafusp alfa	Inhibitor	97.09%	Unkown
HY-E70715	ERBB2 775YVMA776 Recombinant Human Active Protein Kinase		/	Unkown
HY-164387	Sutetinib	Inhibitor	99.27%	Unkown
HY-138072	EMI1	Inhibitor	99.45%	Unkown
HY-103439	GW583340 dihydrochloride	Inhibitor	/	Unkown
HY-10346A	AV-412 free base	Inhibitor	98.10%	Unkown
HY-156912	Tyrosine kinase-IN-7	Inhibitor	99.25%	Unkown
HY-101007A	(+)-Tyrphostin B44	Inhibitor	99.10%	Unkown
HY-145960	MC-Val-Cit-PAB-Amide-TLR7 agonist 4	Agonist	99.39%	Unkown
HY-161618	MJ04	Inhibitor	98.08%	Unkown
HY-13272S2	Dacomitinib-d10 dihydrochloride	Inhibitor	≥95.0%	Unkown
HY-155005	EGFR mutant-IN-2	Inhibitor	97.0%	Unkown
HY-15772S1	Osimertinib-13C,d3		99.14%	Unkown
HY-12008S	Erlotinib-d6 hydrochloride	Inhibitor	98.13%	Unkown
HY-155285	YS-363	Inhibitor	99.52%	Unkown
HY-100499	Tyrphostin AG 528	Inhibitor	98.0%	Unkown
HY-144677	pan-HER-IN-2	Inhibitor	98.10%	Unkown
HY-155358	Os30	Inhibitor	98.34%	Unkown
HY-153111	EGFR/HER2-IN-9	Inhibitor	98.73%	Unkown
HY-N6651	Isocryptotanshinone	Inhibitor	≥98.0%	Unkown
HY-149636	Multi-target kinase inhibitor 2	Inhibitor	99.82%	Unkown
HY-12872B	Nazartinib S-enantiomer		95.10%	Unkown
HY-B0794A	AZ7550 hydrochloride	Inhibitor	98.66%	Unkown
HY-126850	4-Epidoxycycline		/	Unkown
HY-162254	EGFR/ACK1-IN-1	Inhibitor	98.19%	Unkown
HY-131088	N3-PEG8-Phe-Lys-PABC-Gefitinib	Inhibitor	/	Unkown
HY-50895S1	Gefitinib-d6	Inhibitor	98.2%	Unkown
HY-129510	4-Methyl erlotinib	Inhibitor	99.34%	Unkown
HY-131088A	N3-PEG8-Phe-Lys-PABC-Gefitinib TFA	Inhibitor	/	Unkown
HY-158310	SOS1/EGFR-IN-1	Inhibitor	99.54%	Unkown
HY-19617B	EGFR-IN-1 TFA	Inhibitor	99.38%	Unkown
HY-111452	EGFR-IN-85	Inhibitor	/	Unkown
HY-N10103	Neoschaftoside	Modulator	98.04%	Unkown
HY-151048	JBJ-07-149	Inhibitor	99.09%	Unkown
HY-156741	EGFR-IN-87	Inhibitor	/	Unkown
HY-14347	EBE-A22	Control	99.76%	Unkown
HY-P2673A	Lys-Arg-Thr-Leu-Arg-Arg acetate		/	Unkown
HY-183068	AP4-43	Inhibitor	99.76%	Unkown
HY-108486	Herbimycin A	Degrader	99%	Unkown
HY-126319	SU5204	Inhibitor	99.46%	Unkown
HY-108931	AG 1406	Inhibitor	99.03%	Unkown
HY-15772S3	Asandeutertinib	Inhibitor	99.75%	Unkown
HY-147858A	PROTAC EGFR degrader 7 diTFA	Degrader	97.15%	Unkown
HY-P3744	pp60v-src Autophosphorylation site		99.93%	Unkown
HY-10261S	Afatinib-d6	Inhibitor	99.0%	Unkown
HY-183682	AZ14289671	Inhibitor	98.99%	Unkown
HY-157413	YS-67	Inhibitor	99.41%	Unkown
HY-150610	EGFR-IN-69	Inhibitor	99.58%	Unkown
HY-147219	SIAIS164018	Degrader	/	Unkown
HY-B0794S	AZ7550-d5	Inhibitor	/	Unkown
HY-12872A	Nazartinib mesylate	Inhibitor	/	Unkown
HY-P990698	Umizortamig		96.90%	Unkown
HY-21291	SU-4313	Modulator	99.31%	Unkown
HY-123766	EGFR-IN-99	Inhibitor	98.09%	Unkown
HY-P992130	Rolditamig	Inhibitor	95.26%	Unkown
HY-W109039	EGFR ligand-15		97.03%	Unkown
HY-W001520	1-Methyl-1H-pyrrolo[2,3-b]pyridine		/	Unkown
HY-164476	ES-072	Inhibitor	98.05%	Unkown
HY-185832	SYS6010	Inhibitor	/	Unkown
HY-185816	TQB2102	Inhibitor	/	Unkown
HY-135914	JBJ-02-112-05	Inhibitor	/	Unkown
HY-19981B	Derazantinib dihydrochloride	Inhibitor	/	Unkown
HY-18750A	Zorifertinib hydrochloride	Inhibitor	/	Unkown
HY-100520	EGFR-IN-2	Inhibitor	/	Unkown
HY-142283	Dosimertinib	Inhibitor	/	Unkown
HY-143734	HER2-IN-6		/	Unkown
HY-B0793S1	AZ-5104-d2	Inhibitor	/	Unkown
HY-132883	EGFR/CSC-IN-1	Inhibitor	/	Unkown
HY-163354	EGFR-IN-103	Inhibitor	/	Unkown
HY-138298C	Trastuzumab deruxtecan (DAR4)	Inhibitor	/	Unkown
HY-139920A	Oritinib mesylate	Inhibitor	/	Unkown
HY-144048	EGFR-IN-31		/	Unkown
HY-128860	Mutated EGFR-IN-2	Inhibitor	/	Unkown
HY-125841	EGFR mutant-IN-1	Inhibitor	/	Unkown
HY-168968S	ZJY-54	Inhibitor	/	Unkown
HY-112806	ST8155AA1		/	Unkown
HY-138746	EGFR-IN-15	Inhibitor	96.21%	Unkown
HY-131066	EMI48	Inhibitor	99.45%	Unkown
HY-147303	Sacibertinib	Inhibitor	/	Unkown
HY-147407	Imbotolimod	Inhibitor	/	Unkown
HY-152852A	Mefatinib	Inhibitor	98.90%	Unkown
HY-123726	ErbB-1/ErbB-2 tyrosine kinase-IN-1		/	Unkown
HY-10407G	SU 5402 (GMP)	Inhibitor	/	Unkown
HY-137433A	Befotertinib mesylate	Inhibitor	/	Unkown
HY-115951	EGFR/HER2-IN-2	Inhibitor	/	Unkown
HY-152019	EGFR/C797S-IN-1	Inhibitor	/	Unkown
HY-E70703	EGFR d752-759 Recombinant Human Active Protein Kinase		/	Unkown
HY-163453	HER2-IN-19	Inhibitor	/	Unkown
HY-174232	EGFR/CA-IX-IN-1	Inhibitor	/	Unkown
HY-187533	EGFR AUTOTAC-1	Degrader	/	Unkown
HY-179600	Dyrk1A-IN-16	Inhibitor	/	Unkown
HY-181657	EGFR-IN-200	Inhibitor	/	Unkown
HY-175809	SRT6	Inhibitor	/	Unkown
HY-P11752	Cyclo(KLARLLT)	Ligand	/	Unkown
HY-184719	VEGFR-2-IN-88	Inhibitor	/	Unkown
HY-180964	Lys-PEG3-BA	Degrader	/	Unkown
HY-112405	BPIQ-I	Inhibitor	/	Unkown
HY-173188	EGFR-IN-154	Inhibitor	/	Unkown
HY-152144	EGFR-IN-75	Inhibitor	/	Unkown
HY-163418	HER2-IN-17	Inhibitor	/	Unkown
HY-101959	Tyrphostin AG213	Inhibitor	/	Unkown
HY-15772GL	Osimertinib (GMP Like)	Inhibitor	/	Unkown
HY-E70711	EGFR T790M/L858R Recombinant Human Active Protein Kinase		/	Unkown
HY-178057	EGFR-IN-176	Inhibitor	/	Unkown
HY-P11761	HYNIC-H10F	Ligand	/	Unkown
HY-171252	EGFR-IN-145	Inhibitor	/	Unkown
HY-13595R	Chrysophanol (Standard)	Inhibitor	/	Unkown
HY-180536	HB-EGF-IN-1	Inhibitor	/	Unkown
HY-142283BS	N-Desmethyl dosimertinib-d5		/	Unkown
HY-147794	CDK9-IN-41	Inhibitor	98.84%	Unkown
HY-163722	EGFR/DHFR-IN-1	Inhibitor	/	Unkown
HY-E70698	EGFR d746-750/C797S Recombinant Human Active Protein Kinase		/	Unkown
HY-172469	DSPE-PEG1000-GE11		/	Unkown
HY-177009	Tucatinib analog B	Ligand	/	Unkown
HY-50896S1	Erlotinib-13C6	Inhibitor	/	Unkown
HY-131710	PDE5-IN-3	Inhibitor	/	Unkown
HY-158988	EGFR-IN-114	Inhibitor	/	Unkown
HY-163657	HER2-IN-20	Inhibitor	/	Unkown
HY-173118	EGFR-IN-152	Inhibitor	/	Unkown
HY-168623	EGFR-IN-134	Inhibitor	/	Unkown
HY-151981	EGFR-IN-74	Inhibitor	/	Unkown
HY-184720	VEGFR-2-IN-89	Inhibitor	/	Unkown
HY-155074	EGFR-IN-79	Inhibitor	/	Unkown
HY-181776	c-Met-IN-31	Inhibitor	/	Unkown
HY-181775	VEGFR-2/c-Met/EGFR-IN-1	Inhibitor	/	Unkown
HY-P10659	Self-assembling peptide pY1		/	Unkown
HY-157166	EGFR kinase inhibitor 2	Inhibitor	/	Unkown
HY-149633	EGFR/HER2/DHFR-IN-3	Inhibitor	/	Unkown
HY-172091	CZY43	Degrader	/	Unkown
HY-103566A	LY456236 free base	Inhibitor	/	Unkown
HY-163434	PRMT5/EGFR-IN-1	Inhibitor	/	Unkown
HY-P5258	Oligopeptide-41	Inducer	98.05%	Unkown
HY-189146	HDTAC EGFR Degrader-1	Degrader	/	Unkown
HY-172104	EGFR-IN-143	Inhibitor	/	Unkown
HY-181061	COX/5-LO-IN-2	Inhibitor	/	Unkown
HY-E70708	EGFR L861Q Recombinant Human Active Protein Kinase		/	Unkown
HY-185227	EphB4-IN-1	Inhibitor	/	Unkown
HY-184301	EGFR/HER2-IN-20	Inhibitor	/	Unkown
HY-B0793GL	AZ-5104 (GMP Like)	Inhibitor	/	Unkown
HY-175220	4-TCPA	Inhibitor	/	Unkown
HY-146170	Anticancer agent 69	Inhibitor	/	Unkown
HY-178942	EGFR/VEGFR2-IN-9	Inhibitor	/	Unkown
HY-RS04473	Erbb4 Mouse Pre-designed siRNA Set A	Inhibitor	/	Unkown
HY-144605	PROTAC EGFR degrader 3	Inhibitor	97.39%	Unkown
HY-168655	EGFR/VEGFR2-IN-3	Inhibitor	/	Unkown
HY-178448	EGFR-IN-178	Inhibitor	/	Unkown
HY-149401	EGFR-IN-82	Inhibitor	/	Unkown
HY-143445	EGFR-IN-48	Inhibitor	/	Unkown
HY-175316	EGFR-IN-168	Inhibitor	/	Unkown
HY-181056	EGFR/COX-2-IN-3	Inhibitor	99.76%	Unkown
HY-172877	EGFR/BRAFV600E-IN-5	Inhibitor	/	Unkown
HY-144054	EGFR-IN-37	Inhibitor	/	Unkown
HY-173500	MG-3C	Inhibitor	/	Unkown
HY-159519	EGFR/HER2-IN-16	Inhibitor	/	Unkown
HY-P1085	Epidermal Growth Factor Receptor Peptide (985-996)	Chemical	/	Unkown
HY-170497	EGFR-IN-140	Inhibitor	/	Unkown
HY-187838S	Adonertinib	Inhibitor	/	Unkown
HY-P5742	ELAAWCRWGFLLALLPPGIAG		/	Unkown
HY-P11757	Cyclo[K(N3)larllt]	Ligand	/	Unkown
HY-153744	JGK-068S	Inhibitor	/	Unkown
HY-W008914	(E/Z)-CP-724714	Inhibitor	/	Unkown
HY-171884	BI-8128	Inhibitor	/	Unkown
HY-162589	Lw13	Inhibitor	/	Unkown
HY-144097	HER2-IN-8	Inhibitor	/	Unkown
HY-158313	PROTAC EGFR degrader 13	Inhibitor	/	Unkown
HY-172534	BPN-01	Substrate	/	Unkown
HY-P5745A	TYVPANASL TFA		/	Unkown
HY-173619	EGFR-IN-160	Inhibitor	/	Unkown
HY-160564	ZNL-0056	Inhibitor	/	Unkown
HY-175171	Anticancer agent 276	Inhibitor	/	Unkown
HY-144760	EGFR-IN-3	Inducer	/	Unkown
HY-160087	SG3376	Ligand	/	Unkown
HY-147741	DPPY	Inhibitor	/	Unkown
HY-181701	EGFR-IN-202	Inhibitor	/	Unkown
HY-180966	Gly-PEG3-BA	Degrader	/	Unkown
HY-182073	EGFR-IN-207	Inhibitor	/	Unkown
HY-18957B	Lifirafenib maleate	Inhibitor	/	Unkown
HY-164489	KU004	Inhibitor	/	Unkown
HY-E70704	EGFR G719C Recombinant Human Active Protein Kinase		/	Unkown
HY-173038	EGFR-IN-151	Inhibitor	/	Unkown
HY-181714	EGFR-IN-203	Inhibitor	/	Unkown
HY-151377	RET-IN-19	Inhibitor	/	Unkown
HY-146210	EGFR-IN-50	Inhibitor	/	Unkown
HY-163371	EGFR WT/T790M-IN-1	Inhibitor	/	Unkown
HY-189361	EGFR ligand-19		/	Unkown
HY-175009	MRC-G-001	Inhibitor	/	Unkown
HY-158153	EGFR-IN-108	Inhibitor	/	Unkown
HY-144052	EGFR-IN-35	Inhibitor	/	Unkown
HY-178311	EGFR Ligand-Linker Conjugates 4	Ligand	/	Unkown
HY-103630	PROTAC Her3 Degrader-2	Degrader	/	Unkown
HY-162483	EGFR kinase inhibitor 6	Inhibitor	/	Unkown
HY-181659	EGFR-IN-201	Inhibitor	/	Unkown
HY-178242	PROTAC EGFR degrader 16	Degrader	/	Unkown
HY-181097	EGFR-IN-192	Inhibitor	/	Unkown
HY-137028	2′-Thioadenosine	Inhibitor	/	Unkown
HY-161603	EGFR/HER2-IN-14	Inhibitor	/	Unkown
HY-100636A	Gefitinib N-oxide hydrochloride	Inhibitor	/	Unkown
HY-181502	EGFR-IN-197	Inhibitor	/	Unkown
HY-185833	ADC Control Human IgG1-JSSW-001	Inhibitor	/	Unkown
HY-P5742A	ELAAWCRWGFLLALLPPGIAG TFA		/	Unkown
HY-143901	EGFR-IN-40	Inhibitor	/	Unkown
HY-156116	EGFR/CDK2-IN-4	Inhibitor	/	Unkown
HY-50898S2	Lapatinib-d5	Inhibitor	/	Unkown
HY-157402	Topoisomerase II/EGFR-IN-1		/	Unkown
HY-170787	TZEP7	Inhibitor	/	Unkown
HY-163860	EGFR-TK-IN-3	Inhibitor	/	Unkown
HY-P10224	G7-18NATE		/	Unkown
HY-50898S3	Lapatinib-d4-1	Inhibitor	/	Unkown
HY-107450	PROTAC Her3-binding moiety 2	Inhibitor	/	Unkown
HY-181777	Mal-Pip-ValCit-PAB-AZ7550	Inhibitor	/	Unkown
HY-181093	EGFR-IN-191	Inhibitor	/	Unkown
HY-175297	EGFR T790M/VEGFR-2-IN-1	Inhibitor	/	Unkown
HY-180922	EGFR kinase-IN-8	Inhibitor	/	Unkown
HY-157398	EGFR T790M/L858R-IN-3	Inhibitor	/	Unkown
HY-15268	PP487	Inhibitor	/	Unkown
HY-149846	SIQ17	Inhibitor	/	Unkown
HY-P11781	HW12	Control	/	Unkown
HY-169568	EGFR-IN-147	Inhibitor	/	Unkown
HY-161320	EGFR-IN-105	Inhibitor	/	Unkown
HY-103439A	GW583340	Inhibitor	/	Unkown
HY-184311	EGFR-IN-214	Inhibitor	/	Unkown
HY-402309	IGF-1R modulator 1	Modulator	/	Unkown
HY-178442	EGFR-IN-179	Inhibitor	/	Unkown
HY-172156	EGFR-TK-IN-5	Inhibitor	/	Unkown
HY-143874	HER2-IN-7	Inhibitor	/	Unkown
HY-168073	EGFR/VEGFR2-IN-1	Inhibitor	/	Unkown
HY-172795	EGFR-IN-158	Inhibitor	/	Unkown
HY-182031	JS04	Inhibitor	/	Unkown
HY-176744	HER2-IN-22	Inhibitor	/	Unkown
HY-157399	EGFR/HER2-IN-10	Inhibitor	/	Unkown
HY-146473	EGFR-IN-53	Inhibitor	/	Unkown
HY-169982	EGFR-IN-136	Inhibitor	/	Unkown
HY-13314A	Tesevatinib tosylate	Inhibitor	/	Unkown
HY-155118	EGFR-IN-81	Inhibitor	/	Unkown
HY-116091	EGFR-IN-451	Inhibitor	/	Unkown
HY-18298	PD 173955 analog 1	Inhibitor	/	Unkown
HY-145824	EGFR-IN-43	Inhibitor	/	Unkown
HY-182005	EGFR/VEGFR2-IN-12	Inhibitor	/	Unkown
HY-103437	EGFR-IN-80	Inhibitor	/	Unkown
HY-178157	Multi-target kinase-IN-7	Inhibitor	/	Unkown
HY-174415	ZSH-2117	Degrader	/	Unkown
HY-146239	EGFR/HER2/TS-IN-2	Inhibitor	/	Unkown
HY-142679	EGFR-IN-22	Inhibitor	/	Unkown
HY-162602	EGFR-IN-115	Inhibitor	/	Unkown
HY-162332	EGFR-PK/JNK-2-IN-1	Inhibitor	/	Unkown
HY-145844	EGFR-IN-44	Inhibitor	/	Unkown
HY-180541	EGFR-IN-190	Inhibitor	/	Unkown
HY-142680	EGFR-IN-23	Inhibitor	/	Unkown
HY-149824	EGFR T790M/L858R-IN-2	Inhibitor	99.66%	Unkown
HY-147992	EGFR/HER2-IN-4	Inhibitor	/	Unkown
HY-144051	EGFR-IN-34	Inhibitor	/	Unkown
HY-RS04471	Erbb3 Rat Pre-designed siRNA Set A	Inhibitor	/	Unkown
HY-144049	EGFR-IN-32	Inhibitor	/	Unkown
HY-100064S	O-Desmethyl gefitinib-d8	Inhibitor	99.84%	Unkown
HY-163420	HER2-IN-16	Inhibitor	/	Unkown
HY-168559	EGFR-IN-131	Inhibitor	/	Unkown
HY-182817	Len-604	Inhibitor	/	Unkown
HY-164392	TAS-121	Inhibitor	/	Unkown
HY-147997	EGFR-IN-68	Inhibitor	/	Unkown
HY-183120	EGFR T790M/FAK-IN-2	Inhibitor	/	Unkown
HY-163417	HER2-IN-15	Inhibitor	/	Unkown
HY-147862	EGFR-IN-62	Inhibitor	/	Unkown
HY-163880	EGFR-IN-119	Inhibitor	/	Unkown
HY-162323	EGFR-IN-106	Inhibitor	/	Unkown
HY-157994	EGFR WT/T790M-IN-2	Inhibitor	/	Unkown
HY-178440	EGFR/COX-2-IN-2	Inhibitor	/	Unkown
HY-112334	EGFR-IN-198	Inhibitor	/	Unkown
HY-177380	EGFR ligand-14-PEG3-Boc		/	Unkown
HY-168577	KRAS G12D inhibitor 25	Degrader	/	Unkown
HY-161731	DS08701581	Inhibitor	/	Unkown
HY-149518	EGFR/BRAFV600E-IN-3	Inhibitor	/	Unkown
HY-167948	Dacomitinib metabolite M1/2	Inhibitor	/	Unkown
HY-169309	EGFR-IN-133	Inhibitor	/	Unkown
HY-157432	EGFR-IN-97	Inhibitor	/	Unkown
HY-179485	EGFR/VEGFR2-IN-10	Inhibitor	/	Unkown
HY-N9684	Degalactotigonin	Inhibitor	/	Unkown
HY-100663	Gefitinib impurity 2		99.56%	Unkown
HY-165394	Melafolone	Inhibitor	/	Unkown
HY-156097	Anticancer agent 158	Inhibitor	/	Unkown
HY-150908	Brigatinib A	Ligand	/	Unkown
HY-176556	EGFR-IN-167	Inhibitor	/	Unkown
HY-172111	EGFR-IN-144	Inhibitor	/	Unkown
HY-189142	EGFR-IN-217	Inhibitor	/	Unkown
HY-149407	Multi-kinase-IN-4	Inhibitor	/	Unkown
HY-158154	EGFR-IN-110	Inhibitor	/	Unkown
HY-100064S1	O-Desmethyl gefitinib-d6	Inhibitor	/	Unkown
HY-142519	EGFR-IN-27	Inhibitor	/	Unkown
HY-161136	EGFR/STAT3-IN-1	Inhibitor	/	Unkown
HY-147248	Opadotina	Inhibitor	/	Unkown
HY-138298D	Trastuzumab deruxtecan (DAR6)	Inhibitor	/	Unkown
HY-163006	EGFR/c-Met-IN-1	Inhibitor	/	Unkown
HY-143246	EGFR kinase inhibitor 1	Inhibitor	/	Unkown
HY-171443	Lyso-Monosialoganglioside GM3	Inhibitor	/	Unkown
HY-183090	EGFR/VEGFR2-IN-13	Inhibitor	/	Unkown
HY-185276	EGFR-IN-204	Inhibitor	98.57%	Unkown
HY-N3634	Corylifol C		/	Unkown
HY-161923	EGFR-IN-120	Inhibitor	/	Unkown
HY-158177	EGFR T790M/L858R-IN-6	Inhibitor	/	Unkown
HY-144441	NSC81111	Inhibitor	/	Unkown
HY-169427	FRF-06-057	Inhibitor	/	Unkown
HY-161067	EGFR-IN-96	Inhibitor	/	Unkown
HY-P1828	EGFRvIII peptide (PEPvIII)		/	Unkown
HY-151154	EGFR/HER2/DHFR-IN-1	Inhibitor	/	Unkown
HY-178955	EGFR-IN-182	Inhibitor	/	Unkown
HY-153856A	TAS2940 fumarate	Inhibitor	/	Unkown
HY-183788	EGFR-IN-212	Inhibitor	/	Unkown
HY-170968	EGFR-IN-150	Inhibitor	/	Unkown
HY-181829	Ctx-L3	Degrader	/	Unkown
HY-19730A	Olmutinib hydrochloride	Inhibitor	/	Unkown
HY-163663	AZ14133346	Inhibitor	/	Unkown
HY-E70709	EGFR T790M Recombinant Human Active Protein Kinase		/	Unkown
HY-156991	NODAGA-NHS		/	Unkown
HY-160613	EGFR/HER2-IN-11	Inhibitor	/	Unkown
HY-159101	EP26	Inhibitor	/	Unkown
HY-160828	O-Desmethyl dacomitinib	Inhibitor	/	Unkown
HY-164413	CLM3	Inhibitor	/	Unkown
HY-183123	EGFR T790M/FAK-IN-1	Inhibitor	/	Unkown
HY-163000	EGFR-IN-129	Inhibitor	/	Unkown
HY-175292	EGFR WT/T790M-IN-3	Inhibitor	/	Unkown
HY-179140	EGFR/VEGFR2-IN-8	Inhibitor	/	Unkown
HY-141486A	PROTAC PARP/EGFR ligand 1		/	Unkown
HY-162881	DS06652923	Inhibitor	/	Unkown
HY-168514	SOS1/EGFR-IN-2	Inhibitor	/	Unkown
HY-178824	EGFR-IN-180	Inhibitor	/	Unkown
HY-155227	ALK/EGFR-IN-1	Inhibitor	/	Unkown
HY-178116	HER2-IN-23	Inhibitor	/	Unkown
HY-17654	BIEGi-1	Inhibitor	/	Unkown
HY-P10995	TAT-327	Inhibitor	/	Unkown
HY-114535	Jaceidin	Inhibitor	/	Unkown
HY-P10686	CH401 peptide		/	Unkown
HY-155178	Antiproliferative agent-34	Inhibitor	/	Unkown
HY-173492	EGFR-IN-156	Inhibitor	/	Unkown
HY-156114	EGFR/CDK2-IN-2	Inhibitor	/	Unkown
HY-164056	EGFR T790M/L858R-IN-8	Inhibitor	99.20%	Unkown
HY-150782	UNC-CA359	Inhibitor	/	Unkown
HY-112823S	Almonertinib-d6	Inhibitor	/	Unkown
HY-178005	EGFR-IN-174	Inhibitor	/	Unkown
HY-168151	EGFR-IN-128	Inhibitor	/	Unkown
HY-P12120	ErbB-2-binding peptide-2	Ligand	/	Unkown
HY-170543	Dual Galectin-3/EGFR-IN-1	Inhibitor	/	Unkown
HY-179049	EGFR/tubulin-IN-1	Inhibitor	/	Unkown
HY-181142	Antitumor agent-213		/	Unkown
HY-149275	PKM2/PDK1-IN-1	Inhibitor	/	Unkown
HY-175805	EGFR/HDAC-IN-2	Inhibitor	/	Unkown
HY-168876	AZ14240475	Inhibitor	/	Unkown
HY-183292	SH-1092	Inhibitor	/	Unkown
HY-189075	I-0436650	Inhibitor	/	Unkown
HY-P11078	LARLLT		/	Unkown
HY-P10648	Herceptide		/	Unkown
HY-179143	EGFR-IN-185	Inhibitor	/	Unkown
HY-146423	PROTAC EGFR degrader 6	Degrader	/	Unkown
HY-173218	anti-NSCLC agent-1	Inhibitor	/	Unkown
HY-168627	EGFR-IN-135	Inhibitor	/	Unkown
HY-149344	Anticancer agent 133	Inhibitor	/	Unkown
HY-162148	HNPMI	Inhibitor	99.57%	Unkown
HY-183373	EGFR/PARP-1-IN-1	Inhibitor	/	Unkown
HY-161269	EGFR-IN-101	Inhibitor	/	Unkown
HY-176788	EGFR Ligand-Linker Conjugates 1	Inhibitor	/	Unkown
HY-143733	HER2-IN-5	Inhibitor	/	Unkown
HY-163726	GLUT1/EGFR-IN-1	Inhibitor	99.75%	Unkown
HY-180242	EGFR/CDK2-IN-5	Inhibitor	/	Unkown
HY-162623	EGFR/HER2-IN-15	Inhibitor	/	Unkown
HY-161145	EGFR/microtubule-IN-1	Inhibitor	/	Unkown
HY-147996	EGFR-IN-67	Inhibitor	/	Unkown
HY-158176	EGFR T790M/L858R-IN-5	Inhibitor	/	Unkown
HY-144056	EGFR-IN-39	Inhibitor	/	Unkown
HY-161031	EGFR-IN-93	Inhibitor	/	Unkown
HY-177379	EGFR ligand-14		/	Unkown
HY-142283CS	N-Methyl-dosimertinib-d5		/	Unkown
HY-147995	EGFR-IN-64	Inhibitor	/	Unkown
HY-13524A	AG-1478 hydrochloride	Inhibitor	/	Unkown
HY-RS04211	Egfr Rat Pre-designed siRNA Set A	Inhibitor	/	Unkown
HY-151882	EGFR-IN-73	Inhibitor	/	Unkown
HY-168112	EGFR-IN-127	Inhibitor	/	Unkown
HY-161602	EGFR/HER2-IN-13	Inhibitor	/	Unkown
HY-W714853	(+)-Theta-cypermethrin	Ligand	/	Unkown
HY-208666	EGFR-IN-215	Inhibitor	/	Unkown
HY-142681	EGFR-IN-28	Inhibitor	/	Unkown
HY-147967	EGFR-IN-63	Inhibitor	/	Unkown
HY-184497	PROTAC EGFR degrader 18	Degrader	/	Unkown
HY-116277	Z118332870	Inhibitor	/	Unkown
HY-175173	EGFR-IN-166	Inhibitor	/	Unkown
HY-127067	Yuanhuadin	Inhibitor	/	Unkown
HY-184274	EGFR/c-SRC-IN-1	Inhibitor	/	Unkown
HY-E70701	EGFR d747-749/A750P Recombinant Human Active Protein Kinase		/	Unkown
HY-162099	VEGFR-IN-4	Inhibitor	/	Unkown
HY-157912	EGFR-IN-102	Inhibitor	/	Unkown
HY-162360	EGFR-IN-109	Inhibitor	/	Unkown
HY-147802	EGFR-IN-59	Inhibitor	/	Unkown
HY-179150	EGFR-TK-IN-6	Inhibitor	/	Unkown
HY-139884	EGFR-IN-18	Inhibitor	/	Unkown
HY-172621	EGFR-IN-159	Inhibitor	/	Unkown
HY-146782	EGFR-IN-49	Inhibitor	/	Unkown
HY-E70699	EGFR d746-750/T790M/C797S Recombinant Human Active Protein Kinase		/	Unkown
HY-179522	EGFR-IN-186	Inhibitor	/	Unkown
HY-171958	PROTAC EGFR degrader 12	Degrader	/	Unkown
HY-145867	EGFR-IN-45	Inhibitor	/	Unkown
HY-P10792A	HYNIC-H6F	Ligand	/	Unkown
HY-183253	DL149	Ligand	/	Unkown
HY-169308	EGFR-IN-132	Inhibitor	/	Unkown
HY-158018	EGFR-TK-IN-2	Inhibitor	/	Unkown
HY-170665	EGFR T790M/L858R-IN-9	Inhibitor	/	Unkown
HY-176938	AfaPhos1	Inhibitor	/	Unkown
HY-RS04469	ERBB3 Human Pre-designed siRNA Set A	Inhibitor	/	Unkown
HY-177270	CHNQD-01281	Modulator	/	Unkown
HY-13272S3	Dacomitinib-d10	Inhibitor	/	Unkown
HY-151162	HER2-IN-12	Inhibitor	/	Unkown
HY-175608	EGFR-IN-171	Inhibitor	/	Unkown
HY-144794	EGFR-IN-46	Inhibitor	/	Unkown
HY-121828	TX-1123	Inhibitor	/	Unkown
HY-173367	Anticancer agent 271	Inhibitor	/	Unkown
HY-183277	EGFR-IN-209	Inhibitor	/	Unkown
HY-101960	(Z)-Tyrphostin A51	Inhibitor	/	Unkown
HY-E70696	EGFR C797S/L858R Recombinant Human Active Protein Kinase		/	Unkown
HY-P11590	WGYRGFYC	Ligand	/	Unkown
HY-178142	Multi-kinase-IN-7	Inhibitor	/	Unkown
HY-RS04467	Erbb2 Mouse Pre-designed siRNA Set A	Inhibitor	/	Unkown
HY-156470	Multi-kinase-IN-6	Inhibitor	/	Unkown
HY-170661	EGFR-IN-142	Inhibitor	/	Unkown
HY-P11613	DOTA-WC8	Ligand	/	Unkown
HY-161866	EGFR-IN-118	Inhibitor	/	Unkown
HY-181491	Tubulin-IN-64	Inhibitor	/	Unkown
HY-N1988R	Cucurbitacin IIa (Standard)	Inhibitor	/	Unkown
HY-179098	Multi-target kinase-IN-8	Inhibitor	/	Unkown
HY-118900	CP-654577	Inhibitor	/	Unkown
HY-175257	Theophylline-platinum(IV) prodrug-1	Inhibitor	/	Unkown
HY-172470A	DSPE-PEG3400-GE11		/	Unkown
HY-155079A	(R)-DZD1516	Control	98.80%	Unkown
HY-147860	EGFR-IN-61	Inhibitor	/	Unkown
HY-149556	MTX-241F	Inhibitor	/	Unkown
HY-116059	EGFR-IN-199	Inhibitor	/	Unkown
HY-142678	EGFR-IN-21	Inhibitor	/	Unkown
HY-180965	Pro-PEG3-BA	Degrader	/	Unkown
HY-161891	EGFR/Akt-IN-1	Inhibitor	/	Unkown
HY-155969	EGFR-IN-83	Inhibitor	/	Unkown
HY-118175	RG 14921	Inhibitor	/	Unkown
HY-169346	Pred17	Inhibitor	/	Unkown
HY-172471	DSPE-PEG5000-GE11		/	Unkown
HY-175588	EGFR-IN-170	Inhibitor	/	Unkown
HY-184116	A2AR/EGFR-IN-1	Inhibitor	/	Unkown
HY-116504	WB-308	Inhibitor	/	Unkown
HY-151161	EGFR/HER2-IN-8	Inhibitor	/	Unkown
HY-175837	EGFR-IN-172	Inhibitor	/	Unkown
HY-178119	HER4/HER2-IN-1	Inhibitor	/	Unkown
HY-158969	EGFR-IN-113	Inhibitor	/	Unkown
HY-123891	NS-062	Inhibitor	/	Unkown
HY-178283	EGFR-IN-177	Inhibitor	/	Unkown
HY-115952	EGFR/HER2-IN-3	Inhibitor	/	Unkown
HY-162482	EGFR kinase inhibitor 5	Inhibitor	/	Unkown
HY-153557	HER2-IN-13	Inhibitor	/	Unkown
HY-172966	EG31	Inhibitor	/	Unkown
HY-179031	EGFR/VEGFR2-IN-7	Inhibitor	/	Unkown
HY-E70705	EGFR G719S Recombinant Human Active Protein Kinase		/	Unkown
HY-164503	Neptinib	Inhibitor	/	Unkown
HY-181115	EGFR-IN-193	Inhibitor	/	Unkown
HY-100636	Gefitinib N-oxide	Inhibitor	/	Unkown
HY-145823	EGFR-IN-42	Inhibitor	/	Unkown
HY-146228	HSP90-IN-13	Inhibitor	/	Unkown
HY-159512	EGFR kinase inhibitor 7	Inhibitor	/	Unkown
HY-129288	GW837016X	Inhibitor	/	Unkown
HY-169408	EGFR-IN-137	Inhibitor	/	Unkown
HY-143323	HER2-IN-9	Inhibitor	/	Unkown
HY-163402	EGFR-IN-108 chloride	Inhibitor	/	Unkown
HY-163377	AZ5385	Inhibitor	/	Unkown
HY-10261E	(R)-Afatinib	Inhibitor	/	Unkown
HY-180949	EGFR-IN-189	Inhibitor	/	Unkown
HY-168170	EGFR/VEGFR2-IN-2	Inhibitor	/	Unkown
HY-150905	EGFR ligand-2	Inhibitor	/	Unkown
HY-183311	EGFR-IN-211	Inhibitor	/	Unkown
HY-144050	EGFR-IN-33	Inhibitor	/	Unkown
HY-153557A	HER2-IN-14	Inhibitor	/	Unkown
HY-N16557	(Rac)-8-Gingerol	Inhibitor	/	Unkown
HY-P10793	Cyclic(YCDGFYACYMDV)	Inhibitor	/	Unkown
HY-13050A	Sapitinib fumarate	Inhibitor	/	Unkown
HY-168173	EGFR-IN-130	Inhibitor	/	Unkown
HY-173501	EGFR-IN-157	Inhibitor	/	Unkown
HY-151156	EGFR/HER2-IN-6	Inhibitor	/	Unkown
HY-162300	EGFR kinase inhibitor 4	Inhibitor	/	Unkown
HY-161030	EGFR-IN-92	Inhibitor	/	Unkown
HY-133453	PROTAC EGFR degrader 1	Degrader	/	Unkown
HY-144055	EGFR-IN-38	Inhibitor	/	Unkown
HY-178009	EGFR-IN-175	Inhibitor	/	Unkown
HY-172179	EGFR/VEGFR2-IN-5	Inhibitor	/	Unkown
HY-115933	EGFR/BRAF-IN-1	Inhibitor	/	Unkown
HY-176938A	iAfaPhos1		/	Unkown
HY-W777297	Lapatinib-13C2,15N Ditosylate		/	Unkown
HY-178353	EGFR/Cytokine-IN-1	Inhibitor	/	Unkown
HY-175162	EGFR ligand-20	Ligand	/	Unkown
HY-103629	PROTAC Her3 Degrader-1	Inhibitor	/	Unkown
HY-50898S5	Lapatinib-13C,d7	Inhibitor	/	Unkown
HY-109061A	Lazertinib mesylate hydrate	Inhibitor	/	Unkown
HY-164399	SST0116CL1	Degrader	/	Unkown
HY-W174279	Tyrphostin 8	Inhibitor	99.10%	Unkown
HY-155227S	ALK/EGFR-IN-1-d5	Inhibitor	/	Unkown
HY-164988	TX2-120-1	Degrader	/	Unkown
HY-10261S1	Afatinib-d4	Inhibitor	/	Unkown
HY-P10569	Biotin HER-2 substrate peptide		/	Unkown
HY-138298B	Trastuzumab deruxtecan (DAR2)	Inhibitor	/	Unkown
HY-183754	EGFR-IN-213	Inhibitor	/	Unkown
HY-18957A	rel-Lifirafenib	Control	/	Unkown
HY-15772G	Osimertinib (GMP)	Inhibitor	/	Unkown
HY-161968	EGFR/PI3Kα-IN-1	Inhibitor	/	Unkown
HY-113549	Erbstatin	Inhibitor	/	Unkown
HY-158016	Antiproliferative agent-49	Inhibitor	/	Unkown
HY-169216	Multi-target kinase inhibitor 3	Inhibitor	/	Unkown
HY-168433	LSD1/EGFR-IN-1	Inhibitor	/	Unkown
HY-RS04210	Egfr Mouse Pre-designed siRNA Set A	Inhibitor	/	Unkown
HY-170559	EGFR-IN-141	Inhibitor	/	Unkown
HY-147797	EGFR/HER2/CDK9-IN-2	Inhibitor	/	Unkown
HY-181766	EGFR/VEGFR2-IN-11	Inhibitor	/	Unkown
HY-181923	IMP-Zn		/	Unkown
HY-P11890	GPVGPS	Modulator	/	Unkown
HY-161785	EGFR-IN-117	Inhibitor	/	Unkown
HY-P11484	Myosin Regulatory Light Chain MRCL3 (11-24)		/	Unkown
HY-144444	NSC381467	Inhibitor	/	Unkown
HY-157526	EGFR-TK-IN-1	Inhibitor	/	Unkown
HY-156033	EGFR-IN-88	Inhibitor	/	Unkown
HY-146474	EGFR-IN-54	Inhibitor	/	Unkown
HY-179148	EGFR-IN-184	Inhibitor	/	Unkown
HY-173164	EGFR/BRAFV600E-IN-4	Inhibitor	/	Unkown
HY-146132	EGFR-IN-55	Inhibitor	/	Unkown
HY-138627B	AST5902 mesylate	Inhibitor	/	Unkown
HY-120857	BPIQ-II hydrochloride	Inhibitor	/	Unkown
HY-153605	EGFR-IN-77	Inhibitor	/	Unkown
HY-185780	Trastuzumab-DM21	Inhibitor	/	Unkown
HY-173146	EGFR-IN-153	Inhibitor	/	Unkown
HY-187191	Autophagy-IN/Ferroptosis inducer-modulator-1	Inhibitor	/	Unkown
HY-161632	PROTAC EGFR degrader 10	Degrader	/	Unkown
HY-149517	EGFR/BRAFV600E-IN-2	Inhibitor	/	Unkown
HY-179039	EGFR-IN-183	Inhibitor	/	Unkown
HY-146422	PROTAC EGFR degrader 5	Degrader	/	Unkown
HY-172110	Apoptosis inducer 35	Inhibitor	/	Unkown
HY-185460	Pertuzumab-LD3	Inhibitor	/	Unkown
HY-146325	HSP90-IN-11	Degrader	/	Unkown
HY-151573	EGFR/CDK2-IN-1	Inhibitor	/	Unkown
HY-163723	EGFR-IN-116	Inhibitor	/	Unkown
HY-175011	EGFR-IN-165	Inhibitor	/	Unkown
HY-172780	EGFR-IN-161	Inhibitor	/	Unkown
HY-180154	EGFR/BRAFV600E-IN-6	Inhibitor	/	Unkown
HY-179599	Dyrk1A-IN-15	Inhibitor	/	Unkown
HY-151158	EGFR/HER2-IN-7	Inhibitor	/	Unkown
HY-163419	HER2-IN-18	Inhibitor	/	Unkown
HY-144044	EGFR-IN-30	Inhibitor	/	Unkown
HY-137786	EGFR-IN-16	Inhibitor	/	Unkown
HY-178939	EGFR-IN-181	Inhibitor	/	Unkown
HY-144445	NSC114126	Inhibitor	/	Unkown
HY-187517	Anticancer agent 357	Inhibitor	/	Unkown
HY-146471	EGFR-IN-51	Inhibitor	/	Unkown
HY-110328	PKI-166 hydrochloride	Inhibitor	/	Unkown
HY-170932	EGFR/COX-2-IN-1	Inhibitor	/	Unkown
HY-175820	AGW-11	Inhibitor	/	Unkown
HY-146138	EGFR-IN-57	Inhibitor	/	Unkown
HY-147825	EGFR/BRAFV600E-IN-1	Inhibitor	/	Unkown
HY-146154	EGFR-IN-58	Inhibitor	/	Unkown
HY-120412	SKLB188	Inhibitor	/	Unkown
HY-150781	EGFR-IN-71	Inhibitor	/	Unkown
HY-173520	EGFR/HDAC-IN-1	Inhibitor	/	Unkown
HY-162964	EGFR-IN-126	Inhibitor	/	Unkown
HY-146136	EGFR-IN-56	Inhibitor	/	Unkown
HY-178313	EGFR ligand-18	Degrader	/	Unkown
HY-144676	pan-HER-IN-1	Inhibitor	/	Unkown
HY-174414	EGFR/HER2-IN-18	Inhibitor	/	Unkown
HY-149632	EGFR/HER2/DHFR-IN-2	Inhibitor	/	Unkown
HY-156457	EGFR-IN-90	Inhibitor	/	Unkown
HY-114253	ODS-2004436		/	Unkown
HY-10188	SKS-927	Inhibitor	/	Unkown
HY-187692	IRAK4-IN-35	Inhibitor	/	Unkown
HY-149695	EGFR-IN-91	Inhibitor	/	Unkown
HY-RS04474	Erbb4 Rat Pre-designed siRNA Set A	Inhibitor	/	Unkown
HY-177989	ER121	Inhibitor	98.52%	Unkown
HY-160682	EGFR/HER2-IN-12	Inhibitor	/	Unkown
HY-161319	EGFR-IN-104	Inhibitor	/	Unkown
HY-176279	Hsp90-IN-42	Inhibitor	/	Unkown
HY-146472	EGFR-IN-52	Inhibitor	/	Unkown
HY-168427	Avitinib maleate dihydrate	Inhibitor	/	Unkown
HY-181099	EGFR WT/T790M-IN-4	Inhibitor	/	Unkown
HY-E70706	EGFR L718Q Recombinant Human Active Protein Kinase		/	Unkown
HY-104080	HG-5-88-01	Inhibitor	/	Unkown
HY-173314	EGFR-IN-155	Inhibitor	/	Unkown
HY-10368	EGFR/VEGFR2-IN-4	Inhibitor	/	Unkown
HY-182264	Masoprocol tetrapivalate	Inhibitor	/	Unkown
HY-175864	EGFR-IN-173	Inhibitor	/	Unkown
HY-162062	EGFR WT/T790M/L858R-IN-1	Inhibitor	/	Unkown
HY-135216	Antiproliferative agent-54	Inhibitor	/	Unkown
HY-161146	EGFR-IN-100	Inhibitor	/	Unkown
HY-P990049A	Becotatug (powder)	Inhibitor	/	Unkown
HY-182914	NGI-189	Inhibitor	99.29%	Unkown
HY-147826	EGFR-IN-60	Inhibitor	/	Unkown
HY-50898CS	Lapatinib-d4 tosylate	Inhibitor	/	Unkown
HY-12008S1	Erlotinib-13C6 hydrochloride	Inhibitor	/	Unkown
HY-182742	EGFR-IN-208	Inhibitor	/	Unkown
HY-N6678S	(Rac)-Zearalanone-d6	Degrader	/	Unkown
HY-E70695	EGFR C797S Recombinant Human Active Protein Kinase		/	Unkown
HY-172897	EGFR/DHFR-IN-2	Inhibitor	/	Unkown
HY-181479	EGFR-IN-196	Inhibitor	/	Unkown
HY-117852	CGP-59326	Inhibitor	/	Unkown
HY-168064	EGFR-IN-124	Inhibitor	/	Unkown
HY-116138	RG-14467	Inhibitor	/	Unkown
HY-164490	LS-106	Inhibitor	/	Unkown
HY-172623	EGFR/HER2-IN-17	Inhibitor	/	Unkown
HY-P11944	Peptide 22	Chemical	/	Unkown
HY-182064	EGFR-IN-206	Inhibitor	/	Unkown
HY-157324	EGFR-IN-94	Inhibitor	/	Unkown
HY-175635	EGFR/VEGFR2-IN-6	Inhibitor	/	Unkown
HY-175531	EGFR-IN-169	Inhibitor	/	Unkown
HY-P2548	pp60 (v-SRC) Autophosphorylation Site, Phosphorylated		/	Unkown
HY-180823	Topoisomerase II/EGFR-IN-2	Inhibitor	/	Unkown
HY-E70700	EGFR d746-750/T790M/C797S/L858R Recombinant Human Active Protein Kinase		/	Unkown
HY-152852S	Mefatinib-d6 free base	Inhibitor	/	Unkown
HY-10261AS	Afatinib-d6 dimaleate	Inhibitor	/	Unkown
HY-180917	PROTAC EGFR degrader 17	Degrader	/	Unkown
HY-161045	T-1-DOCA	Inhibitor	/	Unkown
HY-RS04470	Erbb3 Mouse Pre-designed siRNA Set A	Inhibitor	/	Unkown
HY-181251	EGFR-IN-195	Inhibitor	/	Unkown
HY-P11760	HER2-targeted peptide H10	Ligand	/	Unkown
HY-147798	EGFR/HER2/CDK9-IN-3	Inhibitor	/	Unkown
HY-183310	EGFR-IN-210	Inhibitor	/	Unkown
HY-156639	EGFR/ErbB-2 inhibitor-1	Inhibitor	/	Unkown
HY-158178	EGFR T790M/L858R-IN-7	Inhibitor	/	Unkown
HY-172961	EGFR-IN-162	Inhibitor	/	Unkown
HY-147994	EGFR/HER2-IN-5	Inhibitor	/	Unkown
HY-162788	EGFR-IN-121	Inhibitor	/	Unkown
HY-174826	EGFR-IN-164	Inhibitor	/	Unkown
HY-P10994	Eps8 peptide 327	Inhibitor	/	Unkown
HY-155200	EGFR-IN-84	Inhibitor	/	Unkown
HY-E70702	EGFR d747-752/P753S Recombinant Human Active Protein Kinase		/	Unkown
HY-147796	EGFR/HER2/CDK9-IN-1	Inhibitor	/	Unkown
HY-162891	EGFR-IN-123	Inhibitor	/	Unkown
HY-156115	EGFR/CDK2-IN-3	Inhibitor	/	Unkown
HY-144053	EGFR-IN-36	Inhibitor	/	Unkown
HY-181166	EGFR-IN-194	Inhibitor	/	Unkown
HY-172160	HER2-IN-21	Inhibitor	/	Unkown
HY-B0793G	AZ-5104 (GMP)	Inhibitor	/	Unkown
HY-179529	EGFR/InhA-IN-1	Inhibitor	/	Unkown
HY-142517	EGFR-IN-25	Inhibitor	/	Unkown
HY-146238	EGFR/HER2/TS-IN-1	Inhibitor	/	Unkown
HY-168492	TrxR/EGFR-IN-1	Inhibitor	/	Unkown
HY-163632	EGFR-IN-112	Inhibitor	/	Unkown
HY-W409652	CLK1/4-IN-2	Inhibitor	/	Unkown
HY-143729	EGFR-IN-29	Inhibitor	/	Unkown
HY-50898S1	Lapatinib-d7 dihydrochloride	Inhibitor	/	Unkown
HY-187334	EGFR-IN-216	Inhibitor	/	Unkown
HY-174231	EGFR-IN-163	Inhibitor	/	Unkown
HY-18213	EGFR-IN-9	Inhibitor	98.69%	Unkown
HY-158175	EGFR T790M/L858R-IN-4	Inhibitor	/	Unkown
HY-170438	EGFR-IN-139		/	Unkown
HY-168469	EGFR-IN-148	Inhibitor	/	Unkown
HY-180196	EGFR-IN-187	Inhibitor	/	Unkown
HY-174841	EGFR/HER2-IN-19	Inhibitor	/	Unkown
HY-169428	EGFR-IN-138		/	Unkown
HY-P0221A	PACAP (1-38), human, ovine, rat TFA	Inducer	/	Unkown
HY-183402	FLLL12	Inhibitor	/	Unkown
HY-W740378	1,2,3,4-Tetrahydro Staurosporin	Inhibitor	/	Unkown
HY-180325	DDC4002	Inhibitor	/	Unkown
HY-169755	Tyrphostin 63	Inhibitor	/	Unkown
HY-135725	D-69491 hydrochloride	Inhibitor	/	Unkown
HY-169566	EGFR-IN-146	Inhibitor	/	Unkown
HY-183397	Avitinib dihydrochloride	Inhibitor	/	Unkown
HY-10325R	CL-387785 (Standard)	Inhibitor	/	Unkown
HY-10263	BMS-554417	Activator	/	Unkown
HY-118032	Bozepinib	Inhibitor	/	Unkown
HY-158829A	SSOe26 sodium scrambled negative control		/	Unkown
HY-116068	DW532	Inhibitor	/	Unkown
HY-N14636	Paeciloquinone B	Inhibitor	/	Unkown
HY-111300	G3130	Degrader	/	Unkown
HY-158829	SSOe26 sodium		/	Unkown
HY-50898S4	Lapatinib-d7	Inhibitor	/	Unkown
HY-W259575	CDKi free base	Inhibitor	/	Unkown
HY-135727	PF-6422899	Inhibitor	/	Unkown
HY-180498	NSC 57148	Inhibitor	/	Unkown
HY-32718S	Pelitinib-d6		/	Unkown
HY-169948	BML-265	Inhibitor	/	Unkown
HY-168305	EGFR ligand-11		/	Unkown
HY-183456	Tyrphostin AG17	Inhibitor	/	Unkown
HY-160068	2-2(t) aptamer sodium	Chemical	99.28%	Unkown
HY-111072	ADS103317		/	Unkown
HY-16069S	Tucatinib-d6	Inhibitor	/	Unkown
HY-19909A	NRC-2694-A	Inhibitor	/	Unkown
HY-32721S	Neratinib-d6	Inhibitor	/	Unkown
HY-117523	(Z)-RG-13022	Inhibitor	/	Unkown
HY-N14637	Paeciloquinone C	Inhibitor	/	Unkown
HY-N14639	Paeciloquinone E	Inhibitor	/	Unkown
HY-15495B	(3S)-Tanzisertib hydrochloride	Inhibitor	/	Unkown
HY-N14638	Paeciloquinone D	Inhibitor	/	Unkown
HY-178740	GI261520A	Inhibitor	/	Unkown
HY-50896S3	Erlotinib-d8	Inhibitor	/	Unkown
HY-164527	Si306	Inhibitor	/	Unkown
HY-158828A	SSO111 sodium scrambled negative control		/	Unkown
HY-114667	Lavendustin C6	Inhibitor	/	Unkown
HY-103443A	HKI-357 dimaleate	Inhibitor	/	Unkown
HY-180480	NSC 104999	Ligand	/	Unkown
HY-183400	BIM-46174	Inhibitor	/	Unkown
HY-163396	EGFR-IN-107	Inhibitor	/	Unkown
HY-50896S2	Erlotinib-d4	Inhibitor	/	Unkown
HY-111250	SYR127063	Inhibitor	/	Unkown
HY-159047	EGFR ligand-10	Degrader	/	Unkown
HY-156487	CNBDA	Inhibitor	/	Unkown
HY-15769A	WHI-P180 hydrochloride	Inhibitor	/	Unkown
HY-184315	LDC8201	Inhibitor	/	Unkown
HY-100742R	GNE-140 racemate (Standard)	Inhibitor	/	Unkown
HY-N20729	Eucommin A	Modulator	/	Unkown
HY-N14635	Paeciloquinone A	Inhibitor	/	Unkown
HY-153887	HyT36(-Cl)	Control	/	Unkown
HY-117252	HS-72		/	Unkown
HY-110045	ZM-306416 hydrochloride	Inhibitor	/	Unkown
HY-158828	SSO111 sodium		/	Unkown
HY-137081	AKOS024836912	Inhibitor	/	Unkown
HY-14674A	CP-724714 succinate	Inhibitor	/	Unkown
HY-183377	DMBT	Inhibitor	/	Unkown
HY-169570	EGFR-IN-149	Inhibitor	/	Unkown
HY-146262	LDC0496	Inhibitor	/	Unkown

Inhibitory Antibodies (60)

Cat. No.	상품명	효과	Purity	Rare Diseases
HY-P9907A	Trastuzumab (anti-HER2)	Inhibitor	99.838%	Unkown
HY-P9S0008	Cetuximab (PBS)	Inhibitor	99.33%	Unkown
HY-P99854	Disitamab	Inhibitor	98.73%	Unkown
HY-P9912A	Pertuzumab (anti-HER2)	Inhibitor	99.10%	Unkown
HY-P990947	Tilatamig	Inhibitor	99.99%	Unkown
HY-P990957	Ficerafusp alfa		99.71%	Unkown
HY-P99866	Duligotuzumab	Inhibitor	99.17%	Unkown
HY-P99684	Laprituximab	Inhibitor	99.74%	Unkown
HY-P990238	Anti-Human/Rat HER2 (neu) Antibody (7.16.4)	Inhibitor	95.00%	Unkown
HY-P991748	Anti-Human/Mouse Amphiregulin Antibody (AR37)	Inhibitor	99.544%	Unkown
HY-P9977A	Amivantamab (FUT8-KO)	Inhibitor	98%	Unkown
HY-P990755	Pamvatamig		95.298%	Unkown
HY-P99892	Serclutamab		99.97%	Unkown
HY-P99948	Etevritamab		97.00%	Unkown
HY-P99324	Tomuzotuximab	Inhibitor	≥99.0%	Unkown
HY-P99715	Losatuxizumab	Inhibitor	99.44%	Unkown
HY-P99406A	Petosemtamab (FUT8-KO)	Degrader	99%	Unkown
HY-P99618	Fidasimtamab	Inhibitor	95.00%	Unkown
HY-P991662	AMG-595 Antibody		96.94%	Unkown
HY-P99558	Timigutuzumab	Inhibitor	97.53%	Unkown
HY-P990978	Caxmotabart		96.56%	Unkown
HY-P99888	Pimurutamab		99.42%	Unkown
HY-P990909	Calotatug		98%	Unkown
HY-P990962	Vislarafusp alfa		98.98%	Unkown
HY-P991159	Ruzaltatug	Inhibitor	95.69%	Unkown
HY-P990695	Lunaxafusp (His Tag)	Inhibitor	/	Unkown
HY-P991780	Anti-Mouse HER2 (domain I) Antibody (H2Mab-304)	Inhibitor	97.589%	Unkown
HY-P992137	Turigrobart	Inhibitor	99.9%	Unkown
HY-P991505	Anti-HER3 Antibody (Ab562)	Antagonist	99.63%	Unkown
HY-P991779	Anti-Mouse/Human/Canine HER2 (domain III) Antibody (H2Mab-19)	Inhibitor	99.05%	Unkown
HY-P991966	Anti-Human/Mouse EGFR Antibody (7A7)		99.45%	Unkown
HY-P992107	Dulpatatug	Inhibitor	99.09%	Unkown
HY-P990972	Azerutamig		/	Unkown
HY-P992140	Varzutamig	Inhibitor	/	Unkown
HY-P990755A	Pamvatamig (FUT8-KO)	Inhibitor	/	Unkown
HY-P991980	H2Mab-139	Inhibitor	/	Unkown
HY-P991967	AVID100 Antibody	Inhibitor	/	Unkown
HY-P991783	Anti-Mouse EGFR (domain I) Antibody (EMab-300)	Inhibitor	/	Unkown
HY-P991979	Erbicin	Inhibitor	/	Unkown
HY-P991969	LR004	Inhibitor	/	Unkown
HY-P991241	Anti-ERBB3/HER3 (29Z6)	Inhibitor	/	Unkown
HY-P990408	Anti-ERBB1/EGFR/HER1 Antibody	Inhibitor	/	Unkown
HY-P991985	Anti-Her4 Antibody	Inhibitor	/	Unkown
HY-P9968A	Nimotuzumab (powder)	Inhibitor	/	Unkown
HY-P991245	Anti-ERBB3/HER3 (SGP1)	Inhibitor	/	Unkown
HY-P991986	Anti-Epiregulin Antibody	Inhibitor	/	Unkown
HY-P990248	Anti-Mouse E-Cadherin/CD324 Antibody (DECMA-1)	Inhibitor	98.53%	Unkown
HY-P992401	M802	Inhibitor	/	Unkown
HY-P991970	REGN3124	Inhibitor	/	Unkown
HY-P991968	HTI-1511 Antibody	Inhibitor	/	Unkown
HY-P991243	MP-RM-1	Inhibitor	96.29%	Unkown
HY-P991092A	IBI-334 (FUT8-KO)	Inhibitor	/	Unkown
HY-P991239	NM-02	Inhibitor	/	Unkown
HY-P992171	ADCT-701 Antibody		/	Unkown
HY-P99295A	Imgatuzumab (FUT8-KO)	Inhibitor	/	Unkown
HY-P991236	MHES0488A	Inhibitor	/	Unkown
HY-P991977	BSI-001	Inhibitor	/	Unkown
HY-P991784	Anti-Mouse/Human EGFR (domain III) Antibody (EMab-88)	Inhibitor	/	Unkown
HY-P991234	COVA208	Degrader	/	Unkown
HY-P991573	Anti-EGFR Antibody (D2C7)	Inhibitor	/	Unkown

Orthologs Information

Species	Symbol	Source	ID
Homo sapiens	Egfr	NCBI	NCBI:1956